Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “lung cancer”
Sponsor: Sutro Biopharma, Inc.
Head and Neck Squamous Cell Carcinoma HNSCC · Non-Small Cell Lung Cancer NSCLC · Esophageal Cancer · Gastric Cancer
United States
- A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and ProstateNot Yet Recruiting
Sponsor: Memorial Sloan Kettering Cancer Center
Neuroendocrine Tumor of the Lung · Neuroendocrine Carcinoma of Lung · Neuroendocrine Carcinoma · Neuroendocrine Carcinoma of Prostate
United States
- A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer PatientsActive Not Recruiting
Sponsor: AstraZeneca
Carcinoma, Non-Small-Cell Lung
China, Hong Kong, India, Mexico, Philippines +5 more
Sponsor: Anhui Medical University
Lung Cancer (NSCLC)
China
- Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung CancerRecruiting
Sponsor: Karen Reckamp, MD, MS
Non Small Cell Lung Cancer · Lung Cancer
United States
- Study to Assess the Efficacy and Safety of Adjuvant Osimertinib in NSCLC With Uncommon EGFRmActive Not Recruiting
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
China
Sponsor: Revolution Medicines, Inc.
NSCLC (Non-small Cell Lung Cancer) · Non-Small Cell Lung Cancer · NSCLC · NSCLC (Non-small Cell Lung Carcinoma)
United States, Australia, Belgium, France, Germany +14 more
- A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid TumorsRecruiting
Sponsor: Arvinas Inc.
Advanced Solid Tumor
United States
- Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman DiseaseSuspended
Sponsor: Case Comprehensive Cancer Center
Castleman's Disease (CD) · Langerhans Cell Histiocytosis (LCH) · Non-Langerhans-Cell Histiocytosis
United States
Sponsor: National Cancer Institute (NCI)
Extensive Stage Lung Small Cell Carcinoma · Stage IV Lung Cancer AJCC v8
United States
Sponsor: Hoffmann-La Roche
Carcinoma, Non-Small-Cell Lung
China
Sponsor: Strand Therapeutics Inc.
Advanced Solid Tumor
United States
- Goal Concordant Care Learning LaboratoryEnrolling By Invitation
Sponsor: Duke University
Cancer · Heart Failure · Copd · Dementia
United States
Sponsor: City of Hope Medical Center
Advanced Lung Carcinoma · Malignant Female Reproductive System Neoplasm · Stage III Lung Cancer AJCC v8 · Stage IIIA Lung Cancer AJCC v8
United States
- Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.Active Not Recruiting
Sponsor: Memorial Sloan Kettering Cancer Center
Lung Cancer
United States
Sponsor: Alliance for Clinical Trials in Oncology
Lung Non-Small Cell Carcinoma
United States
Sponsor: Alliance for Clinical Trials in Oncology
Localized Malignant Solid Neoplasm · Anal Cancer · Bladder (Urothelial, Transitional Cell) Cancer · Breast Cancer
United States
Sponsor: BioNTech SE
Non-small Cell Lung Cancer
United States, Australia, China, Germany, Italy +5 more
Sponsor: Whitehawk Therapeutics, Inc.
Endometrial Cancer · Ovarian Cancer · Ovarian Cancer Metastatic · Ovarian Cancer Metastatic Recurrent
United States
- A Phase Ib Study of GC101 in NSCLCRecruiting
Sponsor: Shanghai Juncell Therapeutics
Non Small Cell Lung Cancer Metastatic · Non Small Cell Lung Cancer
China
Sponsor: Alliance for Clinical Trials in Oncology
Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Ann Arbor Stage I Lymphoma · Ann Arbor Stage II Lymphoma
United States
Sponsor: IDEAYA Biosciences
NSCLC Adenocarcinoma · Gastroesophageal Cancer (GC) · Gastric Adenocarcinoma · Adenocarcinoma of Esophagus
United States
Sponsor: Sichuan University
Non-Small Cell Lung Cancer · Adjuvant Therapy · Immune Checkpoint Inhibitors
China
Sponsor: Karolinska Institutet
Healthy · Gastrointestinal Cancer · Cardiovascular Diseases · Chronic Obstructive Airway Disease
Sweden
- A Phase II Study of GC101 in NSCLCRecruiting
Sponsor: Shanghai Juncell Therapeutics
Non Small Cell Lung Cancer
China